Evidence map›Paper›PMID 35590419›Full record

ArticleSubstance abuse treatment, prevention, and policy2022

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance.

Stephanie A Meyers-Pantele, Maria Luisa Mittal, Sonia Jain, Shelly Sun, Indhu Rammohan, Nadia Fairbairn, M-J Milloy, Kora DeBeck, Kanna Hayashi, Dan Werb

Open access · goldAbstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Stephanie A Meyers-Pantele *Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0507, USA.
Maria Luisa Mittal *Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0507, USA.
Sonia JainDepartment of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
Shelly SunDepartment of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
Indhu RammohanCentre on Drug Policy Evaluation, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
Nadia FairbairnBritish Columbia Centre on Substance Use, Vancouver, BC, Canada.
M-J MilloyBritish Columbia Centre on Substance Use, Vancouver, BC, Canada.
Kora DeBeckBritish Columbia Centre on Substance Use, Vancouver, BC, Canada.
Kanna HayashiBritish Columbia Centre on Substance Use, Vancouver, BC, Canada.
Dan WerbDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0507, USA. dwerb@health.ucsd.edu.
University of California San Diego · USBritish Columbia Centre on Substance Use · CASt. Michael's Hospital · CAUniversity of British Columbia · CA

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDSU01DA038886 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI DEBECK, KORA, HAYASHI, KANNA · 2015 to 2024
$12.1M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
University of California Global Health Institute Program for Fellows and ScholarsR25TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, CRAIG R, STRATHDEE, STEFFANIE A. · 2012 to 2017
$6.4M
Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersU01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2017 to 2024
$4.3M
A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for HIV+ AdultsR01DA039950 · NIDA · UNIVERSITY OF MINNESOTA · PI HORVATH, KEITH JOSEPH · 2015 to 2019
$3.3M
Impacts of a Novel law-enforcement delivered intervention on drug user healthR01DA040648 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVIDSON, PETER JOHN · 2016 to 2021
$2.6M
Preventing HIV by modifying the context for injecting initiationDP2DA040256 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WERB, DANIEL M · 2015 to 2015
$2.3M
AIDS International Training Program in the US Mexico Border RegionD43TW008633 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2010 to 2014
$1.5M
FIC NIH HHS D43 TW008633FIC NIH HHS R25 TW009343NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIDA NIH HHS DP2 DA040256NIDA NIH HHS R01 DA039950NIDA NIH HHS R01 DA040648NIDA NIH HHS T32 DA023356NIDA NIH HHS U01 DA021525NIDA NIH HHS U01 DA038886
6 · The paper itself

Abstract

backgroundEvidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT engagement and providing IDU initiation assistance across poly-drug use practices in Vancouver, Canada.

methodsPreventing Injecting by Modifying Existing Responses (PRIMER) is a prospective study seeking to identify structural interventions that reduce IDU initiation. We employed data from linked cohorts of PWID in Vancouver and extended the findings of a latent profile analysis (LPA). Multivariable logistic regression models were performed separately for the six poly-drug use LPA classes. The outcome was recently assisting others in IDU initiation; the independent variable was recent OAT engagement.

resultsAmong participants (n = 1218), 85 (7.0%) reported recently providing injection initiation assistance. When adjusting for age and sex, OAT engagement among those who reported a combination of high-frequency heroin and methamphetamine IDU and low-to-moderate-frequency prescription opioid IDU and methamphetamine non-injection drug use (NIDU) was associated with lower odds of IDU initiation assistance provision (Adjusted Odds Ratio [AOR]: 0.18, 95% CI: 0.05-0.63, P = 0.008). Significant associations were not detected among other LPA classes.

conclusionsOur findings extend evidence suggesting that OAT may provide a population-level protective effect on the incidence of IDU initiation and suggest that this effect may be specific among PWID who engage in high-frequency methamphetamine and opioid use. Future research should seek to longitudinally investigate potential causal pathways explaining the association between OAT and initiation assistance provision among PWID to develop tailored intervention efforts.

Indexed as

MethamphetamineOpioid-Related DisordersSubstance Abuse, IntravenousAnalgesics, OpioidHumansProspective StudiesAnalgesics, OpioidMethamphetamineHCV preventionHIV preventionMethadoneOpioid agonist treatmentOverdose preventionPersons who inject drugsSuboxoneTreatment as prevention

Identifiers

PMID35590419
PMCPMC9118611
OpenAlexW4280530931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.